Paper38534331
Low Density Lipoprotein Cholesterol Decreases the Expression of Adenosine A2A Receptor and Lipid Rafts-Protein Flotillin-1: Insights on Cardiovascular Risk of Hypercholesterolemia.
Chaptal MC and 13 others. Cells, 2024. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Low Density Lipoprotein Cholesterol Decreases the Expression of Adenosine A2A Receptor and Lipid Rafts-Protein Flotillin-1: Insights on Cardiovascular Risk of Hypercholesterolemia. Papers, record 38534331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38534331
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Low Density Lipoprotein Cholesterol Decreases the Expression of Adenosine A2A Receptor and Lipid Rafts-Protein Flotillin-1: Insights on Cardiovascular Risk of Hypercholesterolemia.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypercholesterolemia | Major topic |
| Cardiovascular Diseases | Major topic |
| Membrane Proteins | Major topic |
| Humans | |
| Cholesterol, LDL | |
| Receptor, Adenosine A2A | |
| Leukocytes, Mononuclear | |
| Adenosine | |
| Risk Factors | |
| Cholesterol | |
| Carrier Proteins | |
| Heart Disease Risk Factors | |
| Membrane Microdomains |
Source PubMed
References75
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22,591,295 | Association of coffee drinking with total and cause-specific mortality. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22591295 | PubMed |
| 2 | 36,769,539 | Advances in the Pathophysiology of Thrombosis in Antiphospholipid Syndrome: Molecular Mechanisms and Signaling through Lipid Rafts. | J Clin Med | 2023 | https://conductscience.org/library/papers/36769539 | PubMed |
| 3 | 28,513,806 | Increased activity of vascular adenosine deaminase in atherosclerosis and therapeutic potential of its inhibition. | Cardiovasc Res | 2016 | https://conductscience.org/library/papers/28513806 | PubMed |
| 4 | 24,090,652 | Potential role of A2A adenosine receptor in traumatic optic neuropathy. | J Neuroimmunol | 2013 | https://conductscience.org/library/papers/24090652 | PubMed |
| 5 | 10,448,520 | The mammalian low-density lipoprotein receptor family. | Annu Rev Nutr | 1999 | https://conductscience.org/library/papers/10448520 | PubMed |
| 6 | 28,220,900 | Membrane cholesterol access into a G-protein-coupled receptor. | Nat Commun | 2017 | https://conductscience.org/library/papers/28220900 | PubMed |
| 7 | 32,225,034 | Flotillins: At the Intersection of Protein S-Palmitoylation and Lipid-Mediated Signaling. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32225034 | PubMed |
| 8 | 15,713,660 | The stomatin/prohibitin/flotillin/HflK/C domain of flotillin-1 contains distinct sequences that direct plasma membrane localization and protein interactions in 3T3-L1 adipocytes. | J Biol Chem | 2005 | https://conductscience.org/library/papers/15713660 | PubMed |
| 9 | 31,504,418 | 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. | Eur Heart J | 2020 | https://conductscience.org/library/papers/31504418 | PubMed |
| 10 | 19,041,138 | Production of an agonist-like monoclonal antibody to the human A2A receptor of adenosine for clinical use. | Mol Immunol | 2009 | https://conductscience.org/library/papers/19041138 | PubMed |
| 11 | 32,256,352 | Ferroptosis and Its Potential Role in Human Diseases. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32256352 | PubMed |
| 12 | 33,117,828 | Overview of the Assessment of Endothelial Function in Humans. | Front Med (Lausanne) | 2020 | https://conductscience.org/library/papers/33117828 | PubMed |
| 13 | 18,218,631 | Restricted collision coupling of the A2A receptor revisited: evidence for physical separation of two signaling cascades. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18218631 | PubMed |
| 14 | 9,495,868 | The A2A adenosine receptor mediates coronary vasodilation. | J Pharmacol Exp Ther | 1998 | https://conductscience.org/library/papers/9495868 | PubMed |
| 15 | 12,475,889 | Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation. | FASEB J | 2003 | https://conductscience.org/library/papers/12475889 | PubMed |
| 16 | 31,848,472 | Mechanisms and regulation of cholesterol homeostasis. | Nat Rev Mol Cell Biol | 2020 | https://conductscience.org/library/papers/31848472 | PubMed |
| 17 | 16,957,081 | Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors. | J Neurosci | 2006 | https://conductscience.org/library/papers/16957081 | PubMed |
| 18 | 16,920,910 | Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. | J Immunol | 2006 | https://conductscience.org/library/papers/16920910 | PubMed |
| 19 | 35,474,963 | Multiparametric platform for profiling lipid trafficking in human leukocytes. | Cell Rep Methods | 2022 | https://conductscience.org/library/papers/35474963 | PubMed |
| 20 | 34,711,342 | Familial Hypercholesterolemia: JACC Focus Seminar 4/4. | J Am Coll Cardiol | 2021 | https://conductscience.org/library/papers/34711342 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,720,808 | Adenosine from high-fat-diet-tolerant monkey-derived Limsolactobacillus reuteri MacFasB02 modulates cholesterol metabolism to alleviate hyperlipidemia and inflammation. | NPJ Sci Food | 2026 | https://conductscience.org/library/papers/41720808 | PubMed |
| 40,801,651 | Synthetic Small-Molecule Ligands Targeted to Adenosine Receptors: Is There Potential Towards Ischemic Heart Disease? | Cells | 2025 | https://conductscience.org/library/papers/40801651 | PubMed |
| 40,668,534 | Purinergic receptors in atherosclerosis: implications for pathophysiology and therapeutic strategies. | J Physiol Biochem | 2025 | https://conductscience.org/library/papers/40668534 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADORA2A | 135 | PubTator's text mining | https://conductscience.org/library/genes/135 | NCBI Gene |
| FLOT1 | 10,211 | PubTator's text mining | https://conductscience.org/library/genes/10211 | NCBI Gene |
| TF | 7,018 | PubTator's text mining | https://conductscience.org/library/genes/7018 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38534331
GET https://conductscience.org/api/papers/v1/38534331/references?page=2